Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

23.71 -0.89 (-3.62%)
Streaming Delayed Price Updated: 9:46 AM EDT, Aug 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Enovis Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Enovis Q2 Earnings Call Highlights ↗
Enovis (NYSE:ENOV) reported second-quarter 2026 sales of $583 million, up 3% on a reported basis and 5% organically, as growth in its Reconstruction business offset a slower but still expanding... 
Via MarketBeat
Topics Earnings Economy
News headline image
Why Enovis (ENOV) Shares Are Sliding Today
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) fell 12.8% in the afternoon session after the company reported second-quar... 
Via StockStory
News headline image
Enovis (NYSE:ENOV) Posts Q2 CY2026 Sales In Line With Estimates
Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 3.2% year on year to $582.8 mill... 
Via StockStory
News headline image
Enovis (ENOV) Reports Q2: Everything You Need To Know Ahead Of Earnings
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday morning. Here’s what to expect. Enovis beat analysts’ reve... 
Via StockStory
Topics Artificial Intelligence
Enovis Corp. (NYSE:ENOV) Beats Q1 Estimates, Reaffirms Guidance ↗
Via Chartmill
News headline image
1 Unprofitable Stock to Own for Decades and 2 Facing Challenges
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Approach with Caution
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after a key industry player warned that changes to some insurance plans could slow U.S. proce... 
Via StockStory
News headline image
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis
Check out the companies making headlines this week: HCA Healthcare (NYSE:HCA): Hospital operator HCA Healthcare (NYSE:HCA) fell by 6.7% on Tuesday after the ... 
Via StockStory
News headline image
Enovis (ENOV) Stock Trades Up, Here Is Why
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.6% in the afternoon session after the company announced the U.S. ... 
Via StockStory
News headline image
Why Enovis (ENOV) Stock Is Trading Up Today
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 15% in the afternoon session after the Centers for Medicare & Medic... 
Via StockStory
News headline image
4 Top Growth Stocks Worth Buying Under $100 Today ↗
These four under-the-radar stocks are built to benefit from powerful secular trends that could reward patient, long-term investors. 
Via The Motley Fool
News headline image
1 Oversold Stock Primed to Rebound and 2 We Find Risky
The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether... 
Via StockStory
Topics Bonds
News headline image
Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1
Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV)... 
Via StockStory
News headline image
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
Over the last six months, Enovis’s shares have sunk to $22.66, producing a disappointing 16.1% loss - a stark contrast to the S&P 500’s 10% gain. This might ... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 Healthcare Stocks That Fall Short
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destocking... 
Via StockStory
News headline image
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now? ↗
Enovis develops orthopedic and rehabilitation devices for healthcare providers, serving a broad spectrum of musculoskeletal patient needs. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Small-Cap Stock to Target This Week and 2 We Turn Down
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Enovis Q1 Earnings Call Highlights ↗
Enovis (NYSE:ENOV) reported a solid start to 2026, with management pointing to share gains in its reconstructive surgery business, stable growth in prevention and recovery, and continued investment in... 
Via MarketBeat
Topics Earnings
News headline image
Enovis (ENOV) Q1 2026 Earnings Transcript ↗
Enovis (ENOV) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Regulatory Compliance World Trade
News headline image
Why Is Enovis (ENOV) Stock Rocketing Higher Today
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 7.6% in the afternoon session after the company reported better-tha... 
Via StockStory
News headline image
Enovis (NYSE:ENOV) Exceeds Q1 CY2026 Expectations
Medical technology company Enovis Corporation (NYSE:ENOV) announced better-than-expected revenue in Q1 CY2026, with sales up 5.4% year on year to $589.2 mill... 
Via StockStory
News headline image
Enovis (ENOV) Q1 Earnings Report Preview: What To Look For
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday before market hours. Here’s what to expect. Enovis missed ... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock on Our Buy List and 2 Facing Headwinds
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory
News headline image
3 Reasons to Sell ENOV and 1 Stock to Buy Instead
Enovis’s stock price has taken a beating over the past six months, shedding 26.8% of its value and falling to $23.41 per share. This might have investors con... 
Via StockStory
Topics Economy
News headline image
1 Value Stock to Research Further and 2 We Turn Down
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t... 
Via StockStory
News headline image
3 Healthcare Stocks with Open Questions
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme... 
Via StockStory
News headline image
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Government Stocks
News headline image
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
Via StockStory
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.